Pharming Group's total assets for Q2 2025 were $446.26M, an increase of 10.68% from the previous quarter. NL:PHARM total liabilities were $206.71M for the fiscal quarter, a 10.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.